世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Global and United States Nootropic Supplements Market Insights, Forecast to 2027


Nootropic Supplements are substances that may improve cognitive function, particularly executive functions, memory, creativity, or motivation, in healthy individuals. Market Analysis and Insight... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2021年10月13日 US$3,900
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

Summary

Nootropic Supplements are substances that may improve cognitive function, particularly executive functions, memory, creativity, or motivation, in healthy individuals.

Market Analysis and Insights: Global and United States Nootropic Supplements Market
This report focuses on global and United States Nootropic Supplements market.
In 2020, the global Nootropic Supplements market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In United States the Nootropic Supplements market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Nootropic Supplements Scope and Market Size
Nootropic Supplements market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Nootropic Supplements market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Nootropic Supplements market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type
Caffeine Free
With Caffeine

Segment by Application
Students
Athletes
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
NOOESIS
Excelerol
Zhou Nutrition
Neurofuse
LFI Labs
Opti-Nutra LTD.
Onnit
Synergy
Cognetix Labs
AlternaScript
Nootrostax
Neurohacker Collective
Mind Lab Pro
CILTEP
Nooflux
EVO-X


ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Nootropic Supplements Product Introduction
1.2 Market by Type
1.2.1 Global Nootropic Supplements Market Size Growth Rate by Type
1.2.2 Caffeine Free
1.2.3 With Caffeine
1.3 Market by Application
1.3.1 Global Nootropic Supplements Market Size Growth Rate by Application
1.3.2 Students
1.3.3 Athletes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Nootropic Supplements Market Size, Estimates and Forecasts
2.1.1 Global Nootropic Supplements Revenue 2016-2027
2.1.2 Global Nootropic Supplements Sales 2016-2027
2.2 Global Nootropic Supplements, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Nootropic Supplements Historical Market Size by Region (2016-2021)
2.3.1 Global Nootropic Supplements Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Nootropic Supplements Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Nootropic Supplements Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Nootropic Supplements Sales Forecast by Region (2022-2027)
2.4.2 Global Nootropic Supplements Revenue Forecast by Region (2022-2027)

3 Global Nootropic Supplements Competitor Landscape by Players
3.1 Global Top Nootropic Supplements Manufacturers by Sales
3.1.1 Global Nootropic Supplements Sales by Manufacturer (2016-2021)
3.1.2 Global Nootropic Supplements Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Nootropic Supplements Manufacturers by Revenue
3.2.1 Key Nootropic Supplements Manufacturers Covered: Ranking by Revenue
3.2.2 Global Nootropic Supplements Revenue by Manufacturers (2016-2021)
3.2.3 Global Nootropic Supplements Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Nootropic Supplements Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Nootropic Supplements Revenue in 2020
3.2.6 Global Nootropic Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Nootropic Supplements Price by Manufacturers
3.4 Global Nootropic Supplements Manufacturing Base Distribution, Product Types
3.4.1 Nootropic Supplements Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nootropic Supplements Product Type
3.4.3 Date of International Manufacturers Enter into Nootropic Supplements Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Nootropic Supplements Market Size by Type (2016-2021)
4.1.1 Global Nootropic Supplements Sales by Type (2016-2021)
4.1.2 Global Nootropic Supplements Revenue by Type (2016-2021)
4.1.3 Nootropic Supplements Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Nootropic Supplements Market Size Forecast by Type (2022-2027)
4.2.1 Global Nootropic Supplements Sales Forecast by Type (2022-2027)
4.2.2 Global Nootropic Supplements Revenue Forecast by Type (2022-2027)
4.2.3 Nootropic Supplements Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Nootropic Supplements Market Size by Application (2016-2021)
5.1.1 Global Nootropic Supplements Sales by Application (2016-2021)
5.1.2 Global Nootropic Supplements Revenue by Application (2016-2021)
5.1.3 Nootropic Supplements Price by Application (2016-2021)
5.2 Nootropic Supplements Market Size Forecast by Application (2022-2027)
5.2.1 Global Nootropic Supplements Sales Forecast by Application (2022-2027)
5.2.2 Global Nootropic Supplements Revenue Forecast by Application (2022-2027)
5.2.3 Global Nootropic Supplements Price Forecast by Application (2022-2027)

6 United States by Players, Type and Application
6.1 United States Nootropic Supplements Market Size YoY Growth 2016-2027
6.1.1 United States Nootropic Supplements Sales YoY Growth 2016-2027
6.1.2 United States Nootropic Supplements Revenue YoY Growth 2016-2027
6.1.3 United States Nootropic Supplements Market Share in Global Market 2016-2027
6.2 United States Nootropic Supplements Market Size by Players (International and Local Players)
6.2.1 United States Top Nootropic Supplements Players by Sales (2016-2021)
6.2.2 United States Top Nootropic Supplements Players by Revenue (2016-2021)
6.3 United States Nootropic Supplements Historic Market Review by Type (2016-2021)
6.3.1 United States Nootropic Supplements Sales Market Share by Type (2016-2021)
6.3.2 United States Nootropic Supplements Revenue Market Share by Type (2016-2021)
6.3.3 United States Nootropic Supplements Price by Type (2016-2021)
6.4 United States Nootropic Supplements Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Nootropic Supplements Sales Forecast by Type (2022-2027)
6.4.2 United States Nootropic Supplements Revenue Forecast by Type (2022-2027)
6.4.3 United States Nootropic Supplements Price Forecast by Type (2022-2027)
6.5 United States Nootropic Supplements Historic Market Review by Application (2016-2021)
6.5.1 United States Nootropic Supplements Sales Market Share by Application (2016-2021)
6.5.2 United States Nootropic Supplements Revenue Market Share by Application (2016-2021)
6.5.3 United States Nootropic Supplements Price by Application (2016-2021)
6.6 United States Nootropic Supplements Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Nootropic Supplements Sales Forecast by Application (2022-2027)
6.6.2 United States Nootropic Supplements Revenue Forecast by Application (2022-2027)
6.6.3 United States Nootropic Supplements Price Forecast by Application (2022-2027)

7 North America
7.1 North America Nootropic Supplements Market Size YoY Growth 2016-2027
7.2 North America Nootropic Supplements Market Facts & Figures by Country
7.2.1 North America Nootropic Supplements Sales by Country (2016-2021)
7.2.2 North America Nootropic Supplements Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Nootropic Supplements Market Size YoY Growth 2016-2027
8.2 Asia Pacific Nootropic Supplements Market Facts & Figures by Region
8.2.1 Asia Pacific Nootropic Supplements Sales by Region (2016-2021)
8.2.2 Asia Pacific Nootropic Supplements Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Nootropic Supplements Market Size YoY Growth 2016-2027
9.2 Europe Nootropic Supplements Market Facts & Figures by Country
9.2.1 Europe Nootropic Supplements Sales by Country (2016-2021)
9.2.2 Europe Nootropic Supplements Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Nootropic Supplements Market Size YoY Growth 2016-2027
10.2 Latin America Nootropic Supplements Market Facts & Figures by Country
10.2.1 Latin America Nootropic Supplements Sales by Country (2016-2021)
10.2.2 Latin America Nootropic Supplements Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Nootropic Supplements Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Nootropic Supplements Market Facts & Figures by Country
11.2.1 Middle East and Africa Nootropic Supplements Sales by Country (2016-2021)
11.2.2 Middle East and Africa Nootropic Supplements Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 NOOESIS
12.1.1 NOOESIS Corporation Information
12.1.2 NOOESIS Description and Business Overview
12.1.3 NOOESIS Nootropic Supplements Sales, Revenue and Gross Margin (2016-2021)
12.1.4 NOOESIS Nootropic Supplements Products Offered
12.1.5 NOOESIS Recent Development
12.2 Excelerol
12.2.1 Excelerol Corporation Information
12.2.2 Excelerol Description and Business Overview
12.2.3 Excelerol Nootropic Supplements Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Excelerol Nootropic Supplements Products Offered
12.2.5 Excelerol Recent Development
12.3 Zhou Nutrition
12.3.1 Zhou Nutrition Corporation Information
12.3.2 Zhou Nutrition Description and Business Overview
12.3.3 Zhou Nutrition Nootropic Supplements Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Zhou Nutrition Nootropic Supplements Products Offered
12.3.5 Zhou Nutrition Recent Development
12.4 Neurofuse
12.4.1 Neurofuse Corporation Information
12.4.2 Neurofuse Description and Business Overview
12.4.3 Neurofuse Nootropic Supplements Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Neurofuse Nootropic Supplements Products Offered
12.4.5 Neurofuse Recent Development
12.5 LFI Labs
12.5.1 LFI Labs Corporation Information
12.5.2 LFI Labs Description and Business Overview
12.5.3 LFI Labs Nootropic Supplements Sales, Revenue and Gross Margin (2016-2021)
12.5.4 LFI Labs Nootropic Supplements Products Offered
12.5.5 LFI Labs Recent Development
12.6 Opti-Nutra LTD.
12.6.1 Opti-Nutra LTD. Corporation Information
12.6.2 Opti-Nutra LTD. Description and Business Overview
12.6.3 Opti-Nutra LTD. Nootropic Supplements Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Opti-Nutra LTD. Nootropic Supplements Products Offered
12.6.5 Opti-Nutra LTD. Recent Development
12.7 Onnit
12.7.1 Onnit Corporation Information
12.7.2 Onnit Description and Business Overview
12.7.3 Onnit Nootropic Supplements Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Onnit Nootropic Supplements Products Offered
12.7.5 Onnit Recent Development
12.8 Synergy
12.8.1 Synergy Corporation Information
12.8.2 Synergy Description and Business Overview
12.8.3 Synergy Nootropic Supplements Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Synergy Nootropic Supplements Products Offered
12.8.5 Synergy Recent Development
12.9 Cognetix Labs
12.9.1 Cognetix Labs Corporation Information
12.9.2 Cognetix Labs Description and Business Overview
12.9.3 Cognetix Labs Nootropic Supplements Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Cognetix Labs Nootropic Supplements Products Offered
12.9.5 Cognetix Labs Recent Development
12.10 AlternaScript
12.10.1 AlternaScript Corporation Information
12.10.2 AlternaScript Description and Business Overview
12.10.3 AlternaScript Nootropic Supplements Sales, Revenue and Gross Margin (2016-2021)
12.10.4 AlternaScript Nootropic Supplements Products Offered
12.10.5 AlternaScript Recent Development
12.11 NOOESIS
12.11.1 NOOESIS Corporation Information
12.11.2 NOOESIS Description and Business Overview
12.11.3 NOOESIS Nootropic Supplements Sales, Revenue and Gross Margin (2016-2021)
12.11.4 NOOESIS Nootropic Supplements Products Offered
12.11.5 NOOESIS Recent Development
12.12 Neurohacker Collective
12.12.1 Neurohacker Collective Corporation Information
12.12.2 Neurohacker Collective Description and Business Overview
12.12.3 Neurohacker Collective Nootropic Supplements Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Neurohacker Collective Products Offered
12.12.5 Neurohacker Collective Recent Development
12.13 Mind Lab Pro
12.13.1 Mind Lab Pro Corporation Information
12.13.2 Mind Lab Pro Description and Business Overview
12.13.3 Mind Lab Pro Nootropic Supplements Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Mind Lab Pro Products Offered
12.13.5 Mind Lab Pro Recent Development
12.14 CILTEP
12.14.1 CILTEP Corporation Information
12.14.2 CILTEP Description and Business Overview
12.14.3 CILTEP Nootropic Supplements Sales, Revenue and Gross Margin (2016-2021)
12.14.4 CILTEP Products Offered
12.14.5 CILTEP Recent Development
12.15 Nooflux
12.15.1 Nooflux Corporation Information
12.15.2 Nooflux Description and Business Overview
12.15.3 Nooflux Nootropic Supplements Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Nooflux Products Offered
12.15.5 Nooflux Recent Development
12.16 EVO-X
12.16.1 EVO-X Corporation Information
12.16.2 EVO-X Description and Business Overview
12.16.3 EVO-X Nootropic Supplements Sales, Revenue and Gross Margin (2016-2021)
12.16.4 EVO-X Products Offered
12.16.5 EVO-X Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Nootropic Supplements Industry Trends
13.2 Nootropic Supplements Market Drivers
13.3 Nootropic Supplements Market Challenges
13.4 Nootropic Supplements Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Nootropic Supplements Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/19 10:26

155.48 円

165.11 円

199.74 円

ページTOPに戻る